supported by The National Key Research and Development Program of China(Nos.2018YFF0215500);National Natural Science Foundation of China(Nos.21105047,51773089,and 51973091);the Natural Science Foundation of Jiangsu Province(Nos.BK20181204 and BK20171258);the Science and Technology Items Fund of Nantong City(Applied Basic Research Programs 2017-N,No.MS12017027-2).
ROS-based tumor therapy based on nanocatalytic medicine has recently been proposed for its tumor-specificity.However,a safe and highly efficient strategy towards getting high enough ROS to kill the hypoxic cancer cell...